Bickston SJ - Search Results

1

Inflammatory bowel disease: short- and long-term treatments.

Bickston SJ, Cominelli F. Bickston SJ, et al. Adv Intern Med. 1998;43:143-74. Adv Intern Med. 1998. PMID: 9506181 Review. No abstract available.

2

Vedolizumab for induction and maintenance of remission in ulcerative colitis: a Cochrane systematic review and meta-analysis.

Mosli MH, MacDonald JK, Bickston SJ, Behm BW, Tsoulis DJ, Cheng J, Khanna R, Feagan BG. Mosli MH, et al. Among authors: bickston sj. Inflamm Bowel Dis. 2015 May;21(5):1151-9. doi: 10.1097/MIB.0000000000000396. Inflamm Bowel Dis. 2015. PMID: 25844963 Review.

3

Do patient preferences influence decisions on treatment for patients with steroid-refractory ulcerative colitis?

Arseneau KO, Sultan S, Provenzale DT, Onken J, Bickston SJ, Foley E, Connors AF Jr, Cominelli F. Arseneau KO, et al. Among authors: bickston sj. Clin Gastroenterol Hepatol. 2006 Sep;4(9):1135-42. doi: 10.1016/j.cgh.2006.05.003. Epub 2006 Jul 10. Clin Gastroenterol Hepatol. 2006. PMID: 16829206

4

Infliximab use in luminal Crohn's disease.

Richter JA, Bickston SJ. Richter JA, et al. Among authors: bickston sj. Gastroenterol Clin North Am. 2006 Dec;35(4):775-93. doi: 10.1016/j.gtc.2006.09.003. Gastroenterol Clin North Am. 2006. PMID: 17129813 Review.

5

Evidence-based medications for the treatment of the inflammatory bowel diseases.

De La Rue SA, Bickston SJ. De La Rue SA, et al. Among authors: bickston sj. Curr Opin Gastroenterol. 2006 Jul;22(4):365-9. doi: 10.1097/01.mog.0000231809.10773.c7. Curr Opin Gastroenterol. 2006. PMID: 16760751 Review.

6

Keeping the M in mind: recombinant human GMCSF and Crohn's disease.

Bickston SJ. Bickston SJ. Inflamm Bowel Dis. 2003 Mar;9(2):132. doi: 10.1097/00054725-200303000-00011. Inflamm Bowel Dis. 2003. PMID: 12769449 Clinical Trial. No abstract available.

7

Future therapies for inflammatory bowel disease.

Bickston SJ, Comerford LW, Cominelli F. Bickston SJ, et al. Curr Gastroenterol Rep. 2003 Dec;5(6):518-23. doi: 10.1007/s11894-003-0043-5. Curr Gastroenterol Rep. 2003. PMID: 14602063 Review.

8

Humanized antibody to the alpha4beta7 integrin for induction of remission in ulcerative colitis.

Behm BW, Bickston SJ. Behm BW, et al. Among authors: bickston sj. Cochrane Database Syst Rev. 2009 Jan 21;(1):CD007571. doi: 10.1002/14651858.CD007571. Cochrane Database Syst Rev. 2009. PMID: 19160337 Updated. Review.

9

Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease.

Bamias G, Martin C 3rd, Marini M, Hoang S, Mishina M, Ross WG, Sachedina MA, Friel CM, Mize J, Bickston SJ, Pizarro TT, Wei P, Cominelli F. Bamias G, et al. Among authors: bickston sj. J Immunol. 2003 Nov 1;171(9):4868-74. doi: 10.4049/jimmunol.171.9.4868. J Immunol. 2003. PMID: 14568967

10

Treatment of luminal and fistulizing Crohn's disease with infliximab.

Comerford LW, Bickston SJ. Comerford LW, et al. Among authors: bickston sj. Gastroenterol Clin North Am. 2004 Jun;33(2):387-406, xi. doi: 10.1016/j.gtc.2004.02.014. Gastroenterol Clin North Am. 2004. PMID: 15177545 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results